These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9243784)

  • 21. [Do some drugs have adverse effects on cartilage?].
    Bertin P; Gillet P; Treves R; Netter P
    Therapie; 1998; 53(1):17-20. PubMed ID: 9773095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis.
    Innes JF; Clayton J; Lascelles BD
    Vet Rec; 2010 Feb; 166(8):226-30. PubMed ID: 20173106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of anti-inflammatory drugs in the treatment of osteoarthritis: a European viewpoint.
    Dougados M
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S9-14. PubMed ID: 11695258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mavacoxib and meloxicam for canine osteoarthritis: a randomised clinical comparator trial.
    Walton MB; Cowderoy EC; Wustefeld-Janssens B; Lascelles BD; Innes JF
    Vet Rec; 2014 Sep; 175(11):280. PubMed ID: 24859353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo effects of carprofen, deracoxib, and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis.
    Sessions JK; Reynolds LR; Budsberg SC
    Am J Vet Res; 2005 May; 66(5):812-7. PubMed ID: 15934608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs.
    Vasseur PB; Johnson AL; Budsberg SC; Lincoln JD; Toombs JP; Whitehair JG; Lentz EL
    J Am Vet Med Assoc; 1995 Mar; 206(6):807-11. PubMed ID: 7759332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placebo-controlled pilot study of the effects of an eggshell membrane-based supplement on mobility and serum biomarkers in dogs with osteoarthritis.
    Muller C; Enomoto M; Buono A; Steiner JM; Lascelles BDX
    Vet J; 2019 Nov; 253():105379. PubMed ID: 31685140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results from a patient survey to assess gastrointestinal burden of non-steroidal anti-inflammatory drug therapy contrasted with a review of data from EVA to determine satisfaction with rofecoxib.
    Steinfeld S; Bjørke PA
    Rheumatology (Oxford); 2002 Apr; 41 Supp 1():23-7; discussion 35-42. PubMed ID: 12173277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro effects of meloxicam on metabolism in articular chondrocytes from dogs with naturally occurring osteoarthritis.
    Budsberg SC; Stoker AM; Johnston SA; Liska W; Reno LR; Cook JL
    Am J Vet Res; 2013 Sep; 74(9):1198-205. PubMed ID: 23977892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with cyclooxygenase-2 inhibitors.
    Lanas A
    Rheumatology (Oxford); 2002 Apr; 41 Supp 1():16-22; discussion 35-42. PubMed ID: 12173276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis.
    Vijarnsorn M; Kwananocha I; Kashemsant N; Jarudecha T; Lekcharoensuk C; Beale B; Peirone B; Lascelles BDX
    BMC Vet Res; 2019 Oct; 15(1):349. PubMed ID: 31623621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment. Corticosteroids and anti-inflammatory drugs.
    Kimberly RP
    Rheum Dis Clin North Am; 1988 Apr; 14(1):203-21. PubMed ID: 3041489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomised controlled masked clinical trial of two treatments for osteoarthritis in dogs.
    Whittem T; Richards L; Alexander J; Beck C; Knight C; Milne M; Rockman M; Saunders R; Tyrrell D
    Aust Vet J; 2021 Jul; 99(7):267-272. PubMed ID: 33904159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A synopsis of medication for degenerative osteoarthritis].
    Grifka J; Müller-Ladner U
    Orthopade; 2004 Jul; 33(7):809-15. PubMed ID: 15179548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoarthritis: a review of treatment options.
    Seed SM; Dunican KC; Lynch AM
    Geriatrics; 2009 Oct; 64(10):20-9. PubMed ID: 20726384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical treatment of osteoarthritis in the horse - a review.
    Goodrich LR; Nixon AJ
    Vet J; 2006 Jan; 171(1):51-69. PubMed ID: 16427582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology and first-line treatment of osteoarthritis.
    Hogue JH; Mersfelder TL
    Ann Pharmacother; 2002 Apr; 36(4):679-86. PubMed ID: 11918520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of carprofen on sulfated glycosaminoglycan metabolism, protein synthesis, and prostaglandin release by cultured osteoarthritic canine chondrocytes.
    Benton HP; Vasseur PB; Broderick-Villa GA; Koolpe M
    Am J Vet Res; 1997 Mar; 58(3):286-92. PubMed ID: 9055976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cartilage metabolism and anti-inflammatory drugs in osteoarthritis.
    Hess EV; Herman JH
    Am J Med; 1986 Nov; 81(5B):36-43. PubMed ID: 3538869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
    Matheson AJ; Figgitt DP
    Drugs; 2001; 61(6):833-65. PubMed ID: 11398914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.